PURPOSE: This phase III trial studies tretinoin and arsenic trioxide in treating patients with newly diagnosed acute promyelocytic leukemia. Standard treatment for acute promyelocytic leukemia involves high doses of a common class of chemotherapy drugs called anthracyclines, which are known t ...More
To learn more about available leukemia clinical trials, contact us at cancer@cchmc.org or 513-636-2799.